Literature DB >> 10523601

Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.

S Steyaert1, R Peleman, M Vaneechoutte, T De Baere, G Claeys, G Verschraegen.   

Abstract

Clostridium tertium was isolated from two immunocompromised patients with septicemia, fever, and gastrointestinal symptoms. The strains were resistant to ceftazidime, cefepime, and clindamycin; intermediately resistant to penicillin; and susceptible to metronidazole, quinolones, and vancomycin.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10523601      PMCID： PMC85761     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Comparison of the E test and a reference agar dilution method for susceptibility testing of anaerobic bacteria.

Authors:  J Wüst; U Hardegger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

2.  Clostridium tertium meningitis as the presenting sign of a meningocele in a twelve-year-old child.

Authors:  A P Kourtis; R Weiner; K Belson; F O Richards
Journal:  Pediatr Infect Dis J       Date:  1997-05       Impact factor: 2.129

3.  Clostridium tertium bacteremia in a patient with aspiration pneumonia: an elusive diagnosis.

Authors:  J R Johnson; F C Tenover
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

4.  Emergence of Clostridium tertium as a pathogen in neutropenic patients.

Authors:  M Thaler; V Gill; P A Pizzo
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

5.  Clostridium tertium septicemia in patients with neutropenia.

Authors:  G Speirs; R E Warren; A Rampling
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

Review 6.  Clostridium tertium bacteremia: 2 cases and review.

Authors:  I B Gosbell; C G Johnson; P J Newton; J Jelfs
Journal:  Pathology       Date:  1996-01       Impact factor: 5.306

7.  Neutropenic enterocolitis associated with Clostridium tertium.

Authors:  N Coleman; G Speirs; J Khan; V Broadbent; D G Wight; R E Warren
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

8.  A cluster of seven cases of Clostridium tertium septicemia in neutropenic patients.

Authors:  M Valtonen; A Sivonen; E Elonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

9.  Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.

Authors:  Thierry Calandra; J Klastersky; H Gaya; M P Glauser; F Meunier; S H Zinner
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245
  9 in total
  4 in total

1.  Clostridium tertium Bacteremia: A Marker of an Underlying Perforated Colonic Diverticular Disease in a Non-Neutropenic Patient With COVID-19.

Authors:  Eltaib Saad; Goar Egoryan; Shanmugha Vigneshwar Padmanabhan; Angkawipa Trongtorsak; Akshaya Ramachandran; Qishuo Zhang; Khalid Mohamed; Harvey J Friedman
Journal:  J Med Cases       Date:  2022-04-12

2.  Clostridium tertium isolated from a necrotizing soft tissue infection in a diabetic but otherwise nonimmunocompromised patient.

Authors:  Elizabeth A Steensma; Christian W Ertl; Leandra H Burke
Journal:  J Am Col Certif Wound Spec       Date:  2011-09-17

3.  Clostridium tertium bacteremia in a patient with glyphosate ingestion.

Authors:  Myung-Jo You; Gee-Wook Shin; Chang-Seop Lee
Journal:  Am J Case Rep       Date:  2015-01-06

4.  Two Cases of Clostridium tertium Infection and Successful Identification of the Organism by Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry Analysis.

Authors:  Yumiko Joichi; Shizuo Kayama; Ikue Hayashi; Makoto Onodera; Maki Furushimo; Yumiko Koba; Michiya Yokozaki; Hiroki Ohge; Motoyuki Sugai
Journal:  Ann Lab Med       Date:  2016-05       Impact factor: 3.464
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.